Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Multigene assessment of genetic risk for women for two or more breast cancers

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06201-ySource: DataRank Database

Multigene assessment of genetic risk for women for two or more breast cancers is a research paper published in Breast Cancer Research and Treatment (2021). On theSindex it has a DataRank of 0.312. It has been cited 7 times.

N/A

0.312DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.76)OA: greenTopics (49)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.312

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (17)

John Kidd ORCID,Ryan Bernhisel ORCID,Susan Shehayeb ORCID,Paul Frankel ORCID,Kathleen R. Blazer ORCID

Live enrichment

PubMed:33826040 PMC:PMC8803157 OpenAlex:https://openalex.org/W3144691967

National Cancer Institute

Grant: R01CA242218

National Cancer Institute

Grant: K08CA234394

National Institutes of Health

Grant: P30CA033572

Conquer Cancer Foundation

Grant: Research Professorship in Breast Cancer Diaparities

National Institutes of Health

Grant: 1R01CA242218-01

Precision approaches to refining TP53-associated cancer risk

National Institutes of Health

Grant: 5K08CA234394-02

Mentored Clinical Scientist Research Career Development Award (Parent K08)

National Institutes of Health

Grant: 5P30CA033572-27

Developmental Funds

Breast Cancer Research Foundation

Dr. Norman & Melinda Payson Professorship

FWCI

0.76

Citation Percentile

0.7%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: Springer TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8803157

publisherhttps://link.springer.com/content/pdf/10.1007/s10549-021-06201-y.pdf

publisherhttps://link.springer.com/article/10.1007/s10549-021-06201-y/fulltext.html

journalhttps://doi.org/10.1007/s10549-021-06201-y

Fields of Study

BRCA gene mutations in cancerBreast Cancer Treatment StudiesGenetic factors in colorectal cancer03 medical and health sciences0302 clinical medicineBreast NeoplasmsFemaleGenes, BRCA2Genetic Predisposition to DiseaseGenetic TestingGerm-Line MutationHumansRisk Factors

MeSH Terms

Breast NeoplasmsFemaleGenetic TestingHumansRisk FactorsGerm-Line MutationGenetic Predisposition to DiseaseGenes, BRCA2

Keywords

Breast cancerCHEK2PALB2MedicineOncologyPenetranceInternal medicineOdds ratioFamily historyCancerGenetic testingGermline mutationGeneticsBiologyMutationGeneBRCA1BRCA2Hereditary Breast CancerSecond Breast CancerMultiple Breast CancersRisk FactorsGenes, BRCA2HumansBreast NeoplasmsFemaleGenetic Predisposition to DiseaseGerm-Line Mutation

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being